MIRA
INFORM REPORT
|
Report Date : |
20.05.2008 |
IDENTIFICATION
DETAILS
|
Name : |
UNION PHARMACEUTIQUE CONSTANTINOISE SARL |
|
|
|
|
Registered Office : |
Zone Industrile Le Rhumel No 49,Constantine Constantine |
|
|
|
|
Country : |
Algeria |
|
|
|
|
Date of Incorporation : |
24.06.1997 |
|
|
|
|
Com. Reg. No.: |
98B0062566 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacturer Basic Pharmaceutical Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
EUR 918 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
name of the company
UNION
PHARMACEUTIQUE CONSTANTINOISE SARL
Registration Briefing
Registration Number: 98B0062566
Registration Date: 24/06/1997
Legal Form: PRIVATE
LIMITED CO
Latest Financials: N/A
Financial Briefing
Nominal Capital: 302,200,000
Algerian Dinars
Issued Capital: N/A
Turnover: 3,800,000
Algerian Dinars
Net Profit: 23,000
Algerian Dinars
Net Worth: N/A
Rating briefing
Current Recommended Credit: 918 EUR
Former Recommended Credit: N/A
Rating Trend: POSITIVE
Payment Record: REGULAR
Original Investigation Details
Company
Name: SARL
UNION PHARMACETIQUE CONSTANTIONISE
Country: AG
Street
Name: ZONE
INDUSTRILE LE RHUMEL NO 49,CONSTANTINE
City
Code: CONSTANTINE
Phone
Number: 00
213 6 61 30 57 51/00 213 31 66 44 11
Fax
Number: 00
213 31 66 44 14
Comments: CONTACT:M/S
UPC
HICHEM.ARABET@GREE.FR
WWW.UPC.DZ
ARABET MED HICHEM
PLANT MANAGER & CEO SONS
Company Details
Company
Name: UNION
PHARMACEUTIQUE CONSTANTINOISE SARL
Also
trades as: UPC
Company
acronym: UPC
SARL
Headquarter
Address: 49
Zone industrielle Le Rhumel,
Constantine,
Constantine
25000,
Algeria
Telephone: +21331
664411
+21331 668581
+21331 668649
Fax: +21331
664414
+21331
664415
E‑Mail: info@upc.dz
/ direction@upc.dz / upc25_cne@yahoo.fr
Web
Site: www.upc.dz
Company was originally started on
14/07/1997
Registration & Legal Details
Current
Legal Form: PRIVATE
LIMITED CO
Registration
Address: 49
Zone industrielle Le Rhumel,
Constantine
25000
Registration
Number: 98B0062566
Registration
Date: 24/06/1997
Year/Date
Company Established: 14/07/1997
Registration
Town: Constantine
Tax
Registration Number: 099725010082812
Capital
Currency: Algerian Dinars
Nominal
Capital: 302,200,000
Paid
Up Capital: 302,200,000
Shareholders
Shareholders:
Name/Address Shares Held % of Voting/Non‑Voting
capital
55.00% (VOTING)
Mr. Saleh ARABET,
Constantine,
Algeria
15.00% (VOTING)
Ms. Malika ARABET,
Constantine,
Algeria
15.00% (VOTING)
Mr. Mohamed‑Redha ARABET,
Constantine,
Algeria
15.00% (VOTING)
Mr. Mohamed‑Hichem ARABET,
Constantine,
Algeria
Principals
Name: Mr
Saleh ARABET
Position
within the company: General
manager
Nationality: Algerian
Can
fluently speak: French
Name: Mr
Mohamed‑Redha ARABET
Position
within the company: Administration
& Financial Director
Nationality: Algerian
Can
fluently speak: French
Name: Ms
Meriem ABBAS
Position
within the company: Development
Director
Nationality: Algerian
Can
fluently speak: French
Name: Mr
Hichem Arabet
Position
within the company: Production
Director
Country
of Birth: Algeria
Nationality: Algerian
Can
fluently speak: French
Company Activities
NACE Codes: 2441 Mfg
basic pharmaceutical products
5146 Wholesale of pharmaceutical goods
The company is involved within the pharmaceutical
drug manufacture, pharmaceutical products and supplies importations and
distribution.
The finished goods are absorbed on a
wholesale basis and exclusively by the local clients.
Local Reporters consider the
investigated company to be MEDIUM in their field of concern.
Contracts
Current Contract with: NORGINE PHARMA
Description
of Contract: Manufacture
of pharmaceutical products
Location:
Country: France
Project
completion date:
Current
Contract with: SCHWARZ
PHARMA
Description
of Contract: manufacture
of pharmaceutical products
Location:
Country: France
Project
completion date:
Operations
Employees Company
Employs: 102
HQ Premises Operates
from: Owned Office , Factory,
Warehouse
Location: Industrial
Area, Main Road
Branches UPC
SARL Centre de distribution Constantine
Operate from heading address
Description of branch: Warehouse
UPC SARL Centre de distribution Alger,
Zone Industrielle Rouiba haouche sbaat echamal zone b ilot
129 07,
Rouiba,
Alger,
Algeria
Description of branch: Warehouse, Shop
Imports
Import
% and type of product: 20%
Raw Materials, 50% Finished Goods
Imports
From: France,
Netherlands, Switzerland, Europe
Importing
Terms: 60
days credit, letters of credit
Agencies: ARROW
GENERIQUE
EISAI SAS
SCHWARZ
EREMPHARMA
NORGINE
Exports
Export % and type of product: Subject does not export
Local Purchases
Purchasing Terms: 30 days
bank transfer
Trading & Selling
Territory: 100%
Nationally
Terms of Sales: 30 days
credit, bank transfer
Additional Information: the company buys
30 % Raw materials locally
Type
of Customer: Group
Companies, Government Bodies, Local Authorities, Wholesalers & Retailers,
Clinics & Hospitals
Related Companies
Information on Related Companies is not
available/applicable
Bankers
Banque
Nationale d'Algerie BNA,
Branch:
Agence Filali, Constantine.
Rue
Filali,
Constantine,
Algeria
Account
Number: 850
0300 300 534/46
Currency: Algerian
Dinars
NATEXIS,
Branch:
Agence de Setif.
Setif
19000,
Algeria
Account
Number: 191‑412
692 09 01
Currency: Algerian
Dinars
SOCIETE
GENERALE,
Branch:
Agence SMK Constantine
Constantine
25000,
Algeria
Account
Number: 021
00 601 113 0000139 29
Currency: Algerian
Dinars
Financial Information
Financial Interview Date: 19/05/2008
Source: Mohamed Rheda
Arabet Financial Director
Figures are: Official
Figures
Currency: Algerian Dinars
Months Sales Figures Sales Gross
Profit/Loss Net
Profit/Loss
12 31/12/2007 3,800,000.00 23,000
12 31/12/2006 3,258,604.00 44,391,493 37,362
12 31/12/2005 2,622,000.00 46,856,276 39,482
Payments
Subject's payments reported to
be: REGULAR
Interview & Reporter Comments
Name/Title: Mohamed
Rheda Arabet Financial Director
Comment: Subject has
confirmed the general details shown in the report.
Expansion
Plans: The
company intends the Extension of the Manufacturing unit and increase in the
production.
The subjects intends also to start
exporting to Asia ( India and South Korea).
Reporter
Comment: In
the interview conducted with Mr.Mohamed Rheda Arabet,he confirmed details shown
in this report.
The correct name of the company
and contact details as mentioned in the report. As per Algerian Commercial law
companies, except the quoted public limited ones, are not required to file their financials and are under no
obligation to provide such details to third parties, representatives and or correspondents
representing international and or local clientele
‑History of UNION PHARMACEUTIQUE CONSTANTINOISE:
Creation in June 1997, the
company specialized in the activity of wholesaler distributor of pharmaceutical
products. Since 1998, She was implied in the importation of a diversified range
of pharmaceutical products, acquired near important international laboratories.
And since August 2003 in the manufacture and the local conditioning of drugs
for the use of human medicine.
‑Ranges of the offer of UNION PHARMACEUTICAL CONSTANTINOISE
SARL:
* Milk, condensed and dried for babies.
* Parapharmaceutical preparations:Skin and wound
disinfectants
* antiburn preparations,Insectbite lotions,Oils, medicated.
* Dairy products: Milk.
* Pharmaceuticals: Medicines,Pharmaceutical oils and Vaseline
* Serums and vaccines,Vitamins, hormones and organ
extracts.
‑Range of the production of the company according to
it's use:
The company produce a drugs for the:
* Nervous system
* Cardiovascular
* Gastro‑enterology
* Respiratory system
* Angiology
* Metabolic disorders
‑Some Marks imported by
UNION PHARMACEUTICAL CONSTANTINOISE SARL :
* CONTRACIDE,
drinkable suspension drug.
* MERCK SHARP ET
DHOME
* BRISTOL MYERS
SQUIBB
* BAYER SCHERING
PHARMA
* SCHERING PLOUGH
* GROUPE CHIESI
* GROUPE RECORDATI
* FRILAB
* LEO
* GILBERT
* SCHWARZ PHARMA
* UCB
* ASTRA ZENEKA
* JANSSEN CILAG
* LIFE SCAN
* THEA
‑The current credit and current liability of UNION
PHARMACEUTICAL
CONSTANTINOISE SARL (31/12/2006):
* current credit:
2179553651.25 AD.
* current
liability: 2179553651.25 AD.
Conclusions
Local
Reputation: The
company being investigated is considered by local reporters to be a Fair /
Normal Trade Risk.
General Conclusion: Local
informants consider granting of credit to be a fair trade risk.
Owner/Shareholders
Comments: All or most of
the owners / shareholders have an active participation in the running of the
business.
Financial
Results Trend: Financial
Information indicates that the business activities of the company are showing
an upward turn.
Age of Business: The
company is a long established family run business.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)